Pharmaceutical compositions for preventing or treating inflammatory diseases using Trachelospermi caulis partitionated extract and its manufacture method
The present invention relates to a pharmaceutical composition for treating and preventing inflammatory diseases comprising an ethyl acetate fraction of dried extract of Trachelospermi caulis as an active ingredient and a method for producing the fraction. More particularly, the present invention relates to a composition for preventing and treating inflammatory diseases comprising an ethyl acetate fraction of dried extract of Trachelospermi caulis as an active ingredient, in which the extract of Trachelospermi caulis is refined and concentrated to contain 0.05&tilde；12% by weight of arctigenin as an index material, and a method for producing the fraction.본 발명은 낙석등 건조 추출물의 에틸아세테이트 분획물을 유효성분으로 함유하는 염증성 질환 치료 및 예방용 약제학적 조성물 및 이의 제조방법에 관한 것으로서, 더욱 상세하게는 낙석등 건조 추출물의 에틸아세테이트 분획물(partition)로서, 지표물질인 악티제닌이 0.05~12 중량%가 함유되도록 정제 및 농축한 추출물을 유효성분으로 함유하는 염증성 질환 예방 및 치료용 조성물과 상기 분획물의 제조방법에 관한 것이다.
